GO:0032728 positive regulation of interferon-beta production: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032728 describes any process that activates or increases the frequency, rate, or extent of interferon-beta (IFN-beta) production, a central cytokine in antiviral and antitumor immunity.
• IRF-7 is the master transcription factor that amplifies type-I interferon production, including IFN-beta, through a positive-feedback loop.
• DNA exonuclease Trex1 degrades cytosolic DNA and thereby limits radiotherapy-induced IFN-beta production, linking DNA damage to immune activation.
• Endoplasmic reticulum stress modulates endometrial IFN-beta production, showing that cellular stress pathways intersect with IFN-beta regulation.
• PARP14 is an interferon-induced host factor that promotes IFN production and affects replication of multiple viruses.
• SHP2 and Gsk3beta reciprocally regulate TLR2-mediated IFN-beta production, illustrating kinase/phosphatase control of this process.
Description
Interferon-beta (IFN-beta) is a type I interferon that is rapidly produced by many cell types in response to viral infection, cytosolic DNA, and other danger signals. The Gene Ontology term GO:0032728, positive regulation of interferon-beta production, captures all molecular events that increase the frequency, rate, or extent of IFN-beta synthesis and secretion. This term is essential for researchers studying innate immunity, autoimmunity, and cancer immunotherapy because IFN-beta production determines the strength and duration of antiviral and antitumor responses. The process is controlled by a network of transcription factors, kinases, and nucleases that integrate pathogen-sensing and stress signals. Understanding GO:0032728 helps interpret how genetic or pharmacological perturbations shift the balance between protective immunity and immunopathology.
positive regulation of interferon-beta production At A Glance
| GO ID | GO:0032728 |
|---|---|
| GO term | positive regulation of interferon-beta production |
| Ontology | biological_process |
| Synonym | activation of interferon-beta production; positive regulation of IFN-beta production; positive regulation of interferon-beta biosynthetic process; positive regulation of interferon-beta secretion; stimulation of interferon-beta production; up regulation of interferon-beta production; up-regulation of interferon-beta production; upregulation of interferon-beta production |
| Major function | Increases the frequency, rate, or extent of interferon-beta production, a key antiviral and immunomodulatory cytokine. |
| Related process | Type I interferon signaling pathway; innate immune response; response to virus. |
| Key regulators | IRF-7, Trex1, PARP14, SHP2, Gsk3beta, and ER stress pathways. |
| Disease relevance | Cancer immunotherapy, viral infections, autoimmune diseases, and interferonopathies. |
What Is GO:0032728?
GO:0032728 is a biological process term defined as any process that activates or increases the frequency, rate, or extent of interferon-beta production. It includes positive regulation of IFN-beta biosynthetic process, secretion, and overall production, and is synonymous with activation or stimulation of interferon-beta production.
Why Is positive regulation of interferon-beta production Important in Cell Biology?
Positive regulation of interferon-beta production is a central node in innate immunity because IFN-beta orchestrates antiviral defense, modulates adaptive immunity, and can enhance tumor immunogenicity. Dysregulation of this process contributes to viral susceptibility, autoimmune pathology, and variable responses to immunotherapy. Researchers targeting GO:0032728 aim to boost protective IFN-beta in cancer or infection while avoiding excessive interferon-driven inflammation.
• Controls antiviral immunity by amplifying type I interferon responses.
• Determines tumor immunogenicity after radiotherapy through Trex1-dependent DNA sensing.
• Links endoplasmic reticulum stress to endometrial IFN-beta production.
• Involves positive-feedback regulation by novel type-I interferons such as bovine interferon-chi.
• PARP14 promotes IFN production and influences replication of multiple viruses.
• SHP2 and Gsk3beta reciprocally regulate TLR2-mediated IFN-beta production.
• Relevant to autoimmune diseases where excessive IFN-beta contributes to tissue damage.
• A target for cancer immunotherapy strategies aiming to enhance IFN-beta in the tumor microenvironment.
• Important for vaccine adjuvant design and antiviral drug development.
• Provides a mechanistic framework for interpreting CRISPR screens of innate immune regulators.
What Happens During positive regulation of interferon-beta production?
Pathogen sensing and initial induction
In simple terms: Cells detect viral or danger signals and start making IFN-beta.
Positive regulation of IFN-beta production begins when pattern recognition receptors detect viral nucleic acids or other danger signals, leading to activation of transcription factors that drive IFNB1 expression. This initial induction is amplified by downstream signaling that increases the frequency and extent of IFN-beta synthesis.
IRF-7-mediated feedback amplification
In simple terms: A master regulator called IRF-7 boosts IFN-beta production in a positive-feedback loop.
IRF-7 is a master regulator of type-I interferon-dependent immune responses and is essential for the positive-feedback amplification of IFN-beta production. Upon induction, IRF-7 increases the transcription of IFN-beta and other type I interferon genes, thereby raising the rate and extent of IFN-beta production.
Cytosolic DNA degradation by Trex1
In simple terms: An enzyme called Trex1 destroys stray DNA, which can limit IFN-beta production.
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity by degrading cytosolic DNA and thereby limiting IFN-beta production. Loss of Trex1 increases cytosolic DNA accumulation and enhances IFN-beta production, linking DNA damage responses to positive regulation of IFN-beta.
ER stress and PARP14 modulation
In simple terms: Cellular stress and PARP14 can change how much IFN-beta is made.
Endoplasmic reticulum stress response regulates endometrial IFN-beta production, indicating that stress pathways can positively or negatively tune IFN-beta output. PARP14 is an interferon-induced host factor that promotes IFN production and affects replication of multiple viruses, further demonstrating positive regulation through interferon-stimulated genes.
Kinase and phosphatase control
In simple terms: Enzymes like SHP2 and Gsk3beta act as brakes or accelerators for IFN-beta production.
SHP2 and Gsk3beta reciprocally regulate TLR2-mediated IFN-beta production, showing that phosphorylation-dependent signaling can either enhance or suppress the positive regulation of IFN-beta. This balance determines the magnitude and duration of IFN-beta production.
Key Genes Involved in GO:0032728 positive regulation of interferon-beta production
The following genes and proteins are experimentally implicated in the positive regulation of interferon-beta production, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IRF7 | Master transcription factor amplifying type-I interferon production | Knockout and overexpression models to study feedback amplification of IFN-beta |
| TREX1 | DNA exonuclease that degrades cytosolic DNA and limits IFN-beta production | Knockout models to enhance radiotherapy-induced tumor immunogenicity |
| PARP14 | Interferon-induced host factor promoting IFN production | Knockout and overexpression to study viral replication and IFN output |
| PTPN11 (SHP2) | Phosphatase that reciprocally regulates TLR2-mediated IFN-beta production | Point-mutation and knockout to dissect kinase/phosphatase control |
| GSK3B | Kinase that reciprocally regulates TLR2-mediated IFN-beta production | Knockout and inhibitor studies to modulate IFN-beta |
| IFNB1 | Gene encoding interferon-beta, the cytokine whose production is regulated | Knock-in reporters and overexpression to measure production |
| IFNAR1 | Type I interferon receptor subunit required for feedback signaling | Knockout to block feedback amplification |
| IFNAR2 | Type I interferon receptor subunit required for feedback signaling | Knockout to block feedback amplification |
| STAT1 | Transcription factor downstream of IFNAR that supports IFN-beta induction | Knockout to test dependence on type I interferon signaling |
| STAT2 | Transcription factor downstream of IFNAR that supports IFN-beta induction | Knockout to test dependence on type I interferon signaling |
| IRF3 | Transcription factor that initiates IFNB1 expression upon sensing | Knockout to define initial induction step |
| IRF9 | Component of ISGF3 complex mediating type I interferon responses | Knockout to study feedback amplification |
| MAVS | Mitochondrial adaptor in RNA-sensing pathways leading to IFN-beta | Knockout to block RNA virus-induced IFN-beta |
| STING1 | Adaptor in cytosolic DNA-sensing pathways leading to IFN-beta | Knockout to block DNA-induced IFN-beta |
| CGAS | Cytosolic DNA sensor upstream of STING and IFN-beta | Knockout to study DNA-driven IFN-beta production |
| TBK1 | Kinase activating IRF3/IRF7 for IFN-beta transcription | Knockout and point-mutation to dissect signaling |
| IKBKE | Kinase activating IRF3/IRF7 for IFN-beta transcription | Knockout to study non-canonical IFN induction |
| CXCL10 | Chemokine linked to fibroblast activation and IFN-related signaling | Knockout to study tumor microenvironment crosstalk |
How Is positive regulation of interferon-beta production Regulated?
Positive regulation of interferon-beta production is controlled by multiple layers of regulation. IRF-7 provides a positive-feedback loop that amplifies type I interferon responses. Trex1 acts as a negative regulator by degrading cytosolic DNA, thereby limiting IFN-beta production after radiotherapy. Endoplasmic reticulum stress can modulate endometrial IFN-beta production, indicating stress-responsive control. PARP14 promotes IFN production and affects replication of multiple viruses. SHP2 and Gsk3beta reciprocally regulate TLR2-mediated IFN-beta production, showing kinase and phosphatase control. These mechanisms collectively determine the magnitude and duration of IFN-beta output.
positive regulation of interferon-beta production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TREX1 | Cancer radiotherapy response and tumor immunogenicity | Trex1 knockout tumor cells with IFN-beta reporter |
| IRF7 | Viral susceptibility and type I interferon-dependent immunity | IRF7 knockout and overexpression cell lines |
| PARP14 | Viral replication and interferon production | PARP14 knockout cells infected with multiple viruses |
| PTPN11 (SHP2) | TLR2-mediated IFN-beta regulation and inflammatory signaling | SHP2 point-mutation and knockout macrophages |
| GSK3B | TLR2-mediated IFN-beta regulation and inflammatory signaling | GSK3B knockout and inhibitor-treated cells |
Cancer immunotherapy and radiotherapy
Trex1-mediated degradation of cytosolic DNA limits radiotherapy-induced IFN-beta production and tumour immunogenicity, so targeting this pathway can enhance antitumor immunity. FGFR4 promotes CAF activation through the CXCL10-CXCR3 axis in colon cancer, linking IFN-related chemokine signaling to tumor stroma.
Viral infections
PARP14 is an interferon-induced host factor that promotes IFN production and affects replication of multiple viruses, making it a potential target for broad-spectrum antiviral strategies. IRF-7-dependent amplification is essential for type-I interferon-dependent immune responses against viruses.
Autoimmune and inflammatory conditions
Excessive or prolonged IFN-beta production can contribute to autoimmune pathology, and dysregulated type I interferon signaling is implicated in interferonopathies. Understanding positive regulation of IFN-beta production helps identify therapeutic windows for modulating interferon responses.
Reproductive and endometrial biology
Endoplasmic reticulum stress response regulates endometrial IFN-beta production, suggesting that IFN-beta regulation is relevant to reproductive tract immunity and endometrial function.
From positive regulation of interferon-beta production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Trex1 enhance IFN-beta production after DNA damage? | Trex1 knockout cell line with IFN-beta reporter |
| Is IRF7 required for feedback amplification of IFN-beta? | IRF7 knockout and overexpression cell models |
| Does PARP14 promote IFN production during viral infection? | PARP14 knockout cells infected with viruses |
| How do SHP2 and Gsk3beta reciprocally regulate TLR2-mediated IFN-beta? | SHP2 and GSK3B point-mutation knock-in cells |
| Does ER stress modulate endometrial IFN-beta production? | Endometrial cells with ER stress inducers and IFN-beta readout |
| Can CXCL10-CXCR3 axis link FGFR4 to IFN-related tumor stroma? | FGFR4 knockout colon cancer cells and CAF co-cultures |
How to Study the positive regulation of interferon-beta production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| IFN-beta reporter assay | Transcriptional activity of IFNB1 promoter | Screening regulators of IFN-beta production |
| ELISA | Secreted IFN-beta protein levels | Validating positive regulation in cell supernatants |
| RNA-seq | Global transcriptome including interferon-stimulated genes | Defining downstream effects of IFN-beta induction |
| CRISPR knockout screen | Genes required for or limiting IFN-beta production | Identifying regulators such as Trex1 and PARP14 |
| Western blot | Protein levels and phosphorylation of IRF3/IRF7 | Dissecting signaling pathways |
| Immunofluorescence | Nuclear translocation of IRF-7 and IFN-beta expression | Single-cell analysis of feedback amplification |
| Co-immunoprecipitation | Protein-protein interactions in IFN induction complexes | Studying STING-TBK1-IRF3 axis |
| Bioinformatics pathway analysis | Enrichment of IFN-related gene signatures | Interpreting CRISPR screen and omics data |
Transcriptional reporters and RNA-seq
IFN-beta production can be measured using luciferase or fluorescent reporters driven by the IFNB1 promoter, combined with RNA-seq to quantify interferon-stimulated genes. These methods reveal how perturbations in genes such as IRF7 or TREX1 alter the frequency and extent of IFN-beta transcription.
Protein and secretion assays
ELISA and cytokine bead arrays quantify secreted IFN-beta protein, providing a direct readout of positive regulation. These assays are used to validate findings from PARP14, SHP2, and Gsk3beta studies.
Imaging and spatial analysis
Immunofluorescence and live-cell imaging can visualize IRF-7 nuclear translocation and IFN-beta promoter activation in single cells, linking spatial signaling events to production.
CRISPR screening and bioinformatics
Genome-wide CRISPR screens coupled with IFN-beta reporters identify positive and negative regulators of IFN-beta production. Bioinformatics integration of screen hits with transcriptomic and proteomic data helps prioritize candidate genes such as PARP14 and Trex1.
How CRISPR Can Be Used to Study GO:0032728 positive regulation of interferon-beta production
Knockout
CRISPR knockout of negative regulators such as TREX1 can enhance IFN-beta production and tumor immunogenicity, while knockout of positive regulators such as IRF7 or PARP14 reduces IFN-beta output. Knockout models are essential for establishing causality in GO:0032728.
Point Mutation
Point mutations in kinases and phosphatases such as SHP2 and Gsk3beta can dissect phosphorylation-dependent control of TLR2-mediated IFN-beta production. CRISPR point-mutation models allow precise testing of catalytic residues without altering protein levels.
Knock-in
Knock-in of fluorescent or luciferase reporters at the IFNB1 locus enables real-time monitoring of IFN-beta production in live cells. Tagged knock-in of IRF7 or PARP14 can reveal localization and interaction dynamics during positive regulation.
Overexpression
Overexpression of IRF7, PARP14, or interferon-chi can amplify IFN-beta production and is used to study positive-feedback regulation. Overexpression models help identify sufficiency of a candidate regulator in driving GO:0032728.
How EDITGENE Supports positive regulation of interferon-beta production Research
Researchers studying positive regulation of interferon-beta production-related genes often need to determine whether a candidate gene is causally involved in increasing IFN-beta output, and CRISPR-based cell models provide the most direct way to test this. EDITGENE offers a comprehensive suite of gene editing services to support such studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of interferon-beta production research.
Frequently Asked Questions About positive regulation of interferon-beta production
What is GO:0032728?
GO:0032728 is the Gene Ontology term for positive regulation of interferon-beta production, defined as any process that activates or increases the frequency, rate, or extent of interferon-beta production.
What genes are involved in positive regulation of interferon-beta production?
Key genes include IRF7, TREX1, PARP14, PTPN11 (SHP2), GSK3B, and IFNB1, among others.
How does IRF-7 regulate interferon-beta production?
IRF-7 is a master transcription factor that amplifies type-I interferon production, including IFN-beta, through a positive-feedback loop.
What is the role of Trex1 in IFN-beta production?
Trex1 degrades cytosolic DNA and limits radiotherapy-induced IFN-beta production, thereby regulating tumor immunogenicity.
How does PARP14 affect interferon production?
PARP14 is an interferon-induced host factor that promotes IFN production and affects replication of multiple viruses.
Do SHP2 and Gsk3beta regulate IFN-beta?
Yes, SHP2 and Gsk3beta reciprocally regulate TLR2-mediated IFN-beta production.
Can endoplasmic reticulum stress affect IFN-beta production?
Yes, the endoplasmic reticulum stress response regulates endometrial interferon-beta production.
What diseases are linked to dysregulated IFN-beta production?
Dysregulated IFN-beta production is linked to cancer immunotherapy responses, viral infections, autoimmune diseases, and interferonopathies.
How can CRISPR be used to study positive regulation of interferon-beta production?
CRISPR knockout, point mutation, knock-in reporters, and overexpression models can test causality of candidate regulators in IFN-beta production.
What methods measure IFN-beta production?
Reporter assays, ELISA, RNA-seq, Western blot, and CRISPR screens are commonly used to measure IFN-beta production and its regulation.
Conclusion
GO:0032728, positive regulation of interferon-beta production, is a critical biological process that integrates pathogen sensing, transcription factor feedback, and stress signaling to control IFN-beta output. Key regulators such as IRF-7, Trex1, PARP14, SHP2, and Gsk3beta shape the magnitude and duration of IFN-beta production, with direct implications for cancer immunotherapy, antiviral defense, and autoimmune disease. CRISPR-based cell models and bioinformatics approaches provide powerful tools to dissect this process and identify new therapeutic targets.
References
- 1. Vanpouille-Box C et al.. 2017. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.. Nat Commun 8:15618 PMID: 28598415
- 2. Sethuram R et al.. 2023. Endoplasmic reticulum stress response and the regulation of endometrial interferon-beta production.. F S Sci 4(2):151-162 PMID: 37011812
- 3. Honda K et al.. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses.. Nature 434(7034):772-7 PMID: 15800576
- 4. Sun EG et al.. 2025. FGFR4 promotes CAF activation through the CXCL10-CXCR3 axis in colon cancer.. Cell Death Dis 16(1):424 PMID: 40447617
- 5. Guo Y et al.. 2020. A Novel Type-I Interferon Family, Bovine Interferon-Chi, Is Involved in Positive-Feedback Regulation of Interferon Production.. Front Immunol 11:528854 PMID: 33193303
- 6. Parthasarathy S et al.. 2025. PARP14 is an interferon-induced host factor that promotes IFN production and affects the replication of multiple viruses.. mBio 16(10):e0229925 PMID: 40937852
- 8. Park JH et al.. 2017. Reciprocal regulation of TLR2-mediated IFN-β production by SHP2 and Gsk3β.. Sci Rep 7(1):6807 PMID: 28754897
